Quince Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-32.6M | $24.9M |
| FY2019 | — | $115.5M | $51.2M |
| FY2020 | — | $172.3M | $66.8M |
| FY2021 | — | $118.6M | $69.7M |
| FY2022 | $0 | $100.6M | $44.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-32.6M | $24.9M |
| FY2019 | — | $115.5M | $51.2M |
| FY2020 | — | $172.3M | $66.8M |
| FY2021 | — | $118.6M | $69.7M |
| FY2022 | $0 | $100.6M | $44.6M |